QCACX
Price
$43.58
Change
+$0.41 (+0.95%)
Updated
Jul 3 closing price
Net Assets
2.16B
VSMPX
Price
$281.45
Change
+$2.40 (+0.86%)
Updated
Jul 3 closing price
Net Assets
1.82T
Interact to see
Advertisement

QCACX vs VSMPX

Header iconQCACX vs VSMPX Comparison
Open Charts QCACX vs VSMPXBanner chart's image
Federated Hermes MDT All Cap Core C
Price$43.58
Change+$0.41 (+0.95%)
VolumeN/A
Net Assets2.16B
Vanguard Total Stock Mkt Idx Instl Pls
Price$281.45
Change+$2.40 (+0.86%)
VolumeN/A
Net Assets1.82T
QCACX vs VSMPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
QCACX vs. VSMPX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QCACX is a Buy and VSMPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSMPX has more cash in the bank: 1.82T vs. QCACX (2.16B). VSMPX pays higher dividends than QCACX: VSMPX (1.22) vs QCACX (0.00). QCACX was incepted earlier than VSMPX: QCACX (20 years) vs VSMPX (10 years). QCACX (1.94) is less costly to investors than VSMPX (0.02). QCACX is a more actively managed with annual turnover of: 71.00 vs. VSMPX (2.00). QCACX has a lower initial minimum investment than VSMPX: QCACX (1500) vs VSMPX (100000000). VSMPX annual gain was more profitable for investors over the last year : 13.90 vs. QCACX (11.03). VSMPX return over 5 years is better than : 95.69 vs. QCACX (54.59).
QCACXVSMPXQCACX / VSMPX
Total Expense Ratio1.840.029,200%
Annual Report Gross Expense Ratio1.940.029,700%
Fund Existence20 years10 years-
Gain YTD10.4696.426163%
Front LoadN/AN/A-
Min. Initial Investment15001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.16B1.82T0%
Annual Yield % from dividends0.001.22-
Returns for 1 year11.0313.9079%
Returns for 3 years50.9062.1782%
Returns for 5 years54.5995.6957%
Returns for 10 years109.88189.2158%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TRIB0.750.07
+10.12%
Trinity Biotech plc
CATX3.680.29
+8.55%
Perspective Therapeutics
CGEN1.760.02
+1.15%
Compugen Ltd
WHD45.270.01
+0.02%
Cactus
STT109.49N/A
N/A
State Street Corp